Combining existing drug therapy is essential in developing new therapeutic agents in
disease prevention and treatment. In preclinical investigations, combined effect of certain …

The rapid and global spread of a new human coronavirus (SARS-CoV-2) has produced an
immediate urgency to discover promising targets for the treatment of COVID-19. Drug …

Accumulating evidence shows that elevated levels of reactive oxygen species (ROS) are
associated with cancer initiation, growth, and response to therapies. As concentrations …

Drug repurposing has become an effective approach to drug discovery, as it offers a new
way to explore drugs. Based on the Science Citation Index Expanded (SCI-E) and Social …

The rising global burden of cancer has driven considerable efforts into the research and
development of effective anti-cancer agents. Fortunately, with impressive advances in …

Deciphering the variations in the protein interactome is required to reach a systems-level
understanding of tumorigenesis. To accomplish this task, we have considered the clinical …

One in every ten drug candidates fail in clinical trials mainly due to efficacy and safety
related issues, despite in-depth preclinical testing. Even some of the approved drugs such …

Cancer is a leading cause of death worldwide, and the incidence continues to increase.
Despite major research aimed at discovering and developing novel and effective anticancer …

Pomegranate (PMG; Punica granatum L.) fruits possess a well-balanced
nutrient/phytochemical composition, with proven adjuvant benefits in experimental cancer …

Over the past few decades, antimicrobial resistance (AMR) has emerged as an important
threat to public health, resulting from the global propagation of multidrug-resistant strains of …